APA (7th ed.) Citation

G, M., D, M., M, M., M, C., S, T., S, M., . . . A, P. (2017). DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype. British journal of haematology, 177(5), 818. https://doi.org/10.1111/bjh.14115

Chicago Style (17th ed.) Citation

G, Maurizi, Mattiucci D, Mariani M, Ciarlantini M, Traini S, Mancini S, Olivieri A, Leoni P, and Poloni A. "DNA Demethylating Therapy Reverts Mesenchymal Stromal Cells Derived from High Risk Myelodysplastic Patients to a Normal Phenotype." British Journal of Haematology 177, no. 5 (2017): 818. https://doi.org/10.1111/bjh.14115.

MLA (9th ed.) Citation

G, Maurizi, et al. "DNA Demethylating Therapy Reverts Mesenchymal Stromal Cells Derived from High Risk Myelodysplastic Patients to a Normal Phenotype." British Journal of Haematology, vol. 177, no. 5, 2017, p. 818, https://doi.org/10.1111/bjh.14115.